Eli Lilly and Company Stock

Equities

LLY

US5324571083

Pharmaceuticals

Market Closed - Nyse 16:00:02 2024-05-17 EDT 5-day change 1st Jan Change
770 USD -0.15% Intraday chart for Eli Lilly and Company +1.32% +32.09%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2024 * 43B 58.52B Sales 2025 * 52.61B 71.6B Capitalization 693B 944B
Net income 2024 * 11.93B 16.24B Net income 2025 * 16.55B 22.53B EV / Sales 2024 * 16.6 x
Net Debt 2024 * 19.98B 27.19B Net Debt 2025 * 15.29B 20.8B EV / Sales 2025 * 13.5 x
P/E ratio 2024 *
57.6 x
P/E ratio 2025 *
41.4 x
Employees 43,000
Yield 2024 *
0.68%
Yield 2025 *
0.78%
Free-Float 99.8%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.15%
1 week+1.32%
Current month-1.42%
1 month+2.56%
3 months-1.54%
6 months+30.13%
Current year+32.09%
More quotes
1 week
750.53
Extreme 750.53
787.66
1 month
718.30
Extreme 718.3
795.50
Current year
579.05
Extreme 579.05
800.78
1 year
419.80
Extreme 419.8
800.78
3 years
193.11
Extreme 193.11
800.78
5 years
101.36
Extreme 101.36
800.78
10 years
58.22
Extreme 58.22
800.78
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 95-12-31
Director of Finance/CFO 51 00-12-31
President - -
Members of the board TitleAgeSince
Director/Board Member 63 21-01-24
Director/Board Member 68 09-03-31
Director/Board Member 63 04-12-31
More insiders
Date Price Change Volume
24-05-17 770 -0.15% 1,670,317
24-05-16 771.1 -2.02% 2,299,653
24-05-15 787 +3.02% 3,038,253
24-05-14 764 +0.83% 1,956,229
24-05-13 757.7 -0.30% 1,848,926

Delayed Quote Nyse, May 17, 2024 at 04:00 pm

More quotes
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunology diseases (11.1%); - neurology (8.4%): primarily drugs used in treating depression and schizophrenia; - other (3.3%). Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
770 USD
Average target price
850.4 USD
Spread / Average Target
+10.44%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW